PARP1 and gastric cancer: Building upon the functional attributes of PARP and the underlying principles of PARPi-induced tumor cell death, combination strategies involving DNA damage inducers, AKT inhibitors, angiogenesis inhibitors, and other agents are being investigated as promising approaches for the treatment of GC (Figure 4).